Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Thomas W. Burns$5.1B
Market Cap • 23/04/20241998
(há 26 anos)
2015
(9 years ago)
NYSE
Listagem
Aliso Viejo
Sede • California783
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
GKOSSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.